| 1. |
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
- Cochius-den Otter, S, et al.
(författare)
-
The CoDiNOS trial protocol: an international randomised controlled trial of intravenous sildenafil versus inhaled nitric oxide for the treatment of pulmonary hypertension in neonates with congenital diaphragmatic hernia
- 2019
-
Ingår i: BMJ open. - : BMJ. - 2044-6055. ; 9:11, s. e032122-
-
Tidskriftsartikel (refereegranskat)abstract
- Congenital diaphragmatic hernia (CDH) is a developmental defect of the diaphragm that impairs normal lung development, causing pulmonary hypertension (PH). PH in CDH newborns is the main determinant for morbidity and mortality. Different therapies are still mainly based on ‘trial and error’. Inhaled nitric oxide (iNO) is often the drug of first choice. However, iNO does not seem to improve mortality. Intravenous sildenafil has reduced mortality in newborns with PH without CDH, but prospective data in CDH patients are lacking.Methods and analysisIn an open label, multicentre, international randomised controlled trial in Europe, Canada and Australia, 330 newborns with CDH and PH are recruited over a 4-year period (2018–2022). Patients are randomised for intravenous sildenafil or iNO. Sildenafil is given in a loading dose of 0.4 mg/kg in 3 hours; followed by continuous infusion of 1.6 mg/kg/day, iNO is dosed at 20 ppm. Primary outcome is absence of PH on day 14 without pulmonary vasodilator therapy and/or absence of death within the first 28 days of life. Secondary outcome measures include clinical and echocardiographic markers of PH in the first year of life. We hypothesise that sildenafil gives a 25% reduction in the primary outcome from 68% to 48% on day 14, for which a sample size of 330 patients is needed. An intention-to-treat analysis will be performed. A p-value (two-sided) <0.05 is considered significant in all analyses.Ethics and disseminationEthics approval has been granted by the ethics committee in Rotterdam (MEC-2017-324) and the central Committee on Research Involving Human Subjects (NL60229.078.17) in the Netherlands. The principles of the Declaration of Helsinki, the Medical Research Involving Human Subjects Act and the national rules and regulations on personal data protection will be used. Parental informed consent will be obtained.Trial registration numberNTR6982; Pre-results.
|
|
| 5. |
- Keijzer, M., et al.
(författare)
-
Corrosion of 304 stainless steel in molten-carbonate fuel cells
- 1999
-
Ingår i: Journal of the Electrochemical Society. ; 146:7, s. 2508-2516
-
Tidskriftsartikel (refereegranskat)abstract
- The corrosion behavior of 304 stainless steel was characterized with cyclic voltammetry in a eutectic Li/K and Li/Na carbonate melt under anode and cathode gas of the molten-carbonate fuel cell (MCFC). The corrosion rate of 304 steel was determined in four different environments of the MCFC with electrochemical methods and from cross-sectional analysis of corrosion layers. These four environments were open-circuit and MCFC-load conditions both under anode and cathode gas. At open-circuit conditions corrosion was more severe under the oxidizing cathode gas than under the reducing anode gas. On the contrary, at load conditions corrosion was more severe under anode than under cathode gas. The anodic polarization under anode gas enhances corrosion, whereas the high anodic polarization under cathode gas leads to anodic protection. Corrosion currents were measured with chronoamperometry and determined with Tafel extrapolation from quasi-stationary polarization-curve measurements. The difference between the corrosion layer thickness estimated from these corrosion currents and the corrosion layer thickness determined from cross-sectional analysis is mainly due to contributing currents of either the MCFC-anode gas reaction under anode gas or the MCFC-cathode gas reaction under cathode gas.
|
|
| 6. |
- Knaapen, M, et al.
(författare)
-
Establishing a core outcome set for treatment of uncomplicated appendicitis in children: study protocol for an international Delphi survey
- 2019
-
Ingår i: BMJ open. - : BMJ. - 2044-6055. ; 9:5, s. e028861-
-
Tidskriftsartikel (refereegranskat)abstract
- Appendicitis is a global disease affecting roughly 1 in every 12 people in the world, with the highest incidence between ages 10 and 19 years. To date, a wide variety of health outcomes have been reported in randomised controlled trials and meta-analyses evaluating treatments for appendicitis. This is especially the case in studies comparing non-operative treatment with operative treatment. A set of standard outcomes, to be reported in all future trials, is needed to allow for adequate comparison and interpretation of clinical trial results and to make data pooling possible. This protocol describes the development of such a global core outcome set (COS) to allow unified reporting of treatment interventions in children with acute uncomplicated appendicitis.Methods and analysisWe use current international standard methodology for the development and reporting of this COS. Its development consists of three phases: (1) an update of the most recent systematic review on outcomes reported in uncomplicated paediatric appendicitis research to identify additional outcomes, (2) a three-step global Delphi study to identify a set of core outcomes for which there is consensus between parents and (paediatric) surgeons and (3) an expert meeting to finalise the COS and its definitions. Children and young people will be involved through their parents during phase 2 and will be engaged directly using a customised face-to-face approach.Ethics and disseminationThe medical research ethics committee of the Academic Medical Center Amsterdam has approved the study. Each participating country/research group will ascertain ethics board approval. Electronic informed consent will be obtained from all participants. Results will be presented in peer-reviewed academic journals and at (international) conferences.Trial registration numberCOMET registration: 1119
|
|
| 7. |
- Estrada, Karol, et al.
(författare)
-
A genome-wide association study of northwestern Europeans involves the C-type natriuretic peptide signaling pathway in the etiology of human height variation.
- 2009
-
Ingår i: Human molecular genetics. - : Oxford University Press (OUP). - 1460-2083 .- 0964-6906. ; 18:18, s. 3516-24
-
Tidskriftsartikel (refereegranskat)abstract
- Northwestern Europeans are among the tallest of human populations. The increase in body height in these people appears to have reached a plateau, suggesting the ubiquitous presence of an optimal environment in which genetic factors may have exerted a particularly strong influence on human growth. Therefore, we performed a genome-wide association study (GWAS) of body height using 2.2 million markers in 10 074 individuals from three Dutch and one German population-based cohorts. Upon genotyping, the 12 most significantly height-associated single nucleotide polymorphisms (SNPs) from this GWAS in 6912 additional individuals of Dutch and Swedish origin, a genetic variant (rs6717918) on chromosome 2q37.1 was found to be associated with height at a genome-wide significance level (P(combined) = 3.4 x 10(-9)). Notably, a second SNP (rs6718438) located approximately 450 bp away and in strong LD (r(2) = 0.77) with rs6717918 was previously found to be suggestive of a height association in 29 820 individuals of mainly northwestern European ancestry, and the over-expression of a nearby natriuretic peptide precursor type C (NPPC) gene, has been associated with overgrowth and skeletal anomalies. We also found a SNP (rs10472828) located on 5p14 near the natriuretic peptide receptor 3 (NPR3) gene, encoding a receptor of the NPPC ligand, to be associated with body height (P(combined) = 2.1 x 10(-7)). Taken together, these results suggest that variation in the C-type natriuretic peptide signaling pathway, involving the NPPC and NPR3 genes, plays an important role in determining human body height.
|
|
| 8. |
- Keijzer, Twan, et al.
(författare)
-
Secure State Estimation Under Actuator and Sensor Attacks Using Sliding Mode Observers
- 2023
-
Ingår i: IEEE Control Systems Letters. - : Institute of Electrical and Electronics Engineers (IEEE). - 2475-1456. ; 7, s. 2071-2076
-
Tidskriftsartikel (refereegranskat)abstract
- Interconnections in modern systems make them vulnerable to adversarial attackers both by corrupting communication channels and compromising entire subsystems. The field of secure state estimation (SSE) aims to provide correct state estimation even when an unknown part of the measurement signals is corrupted. In this letter, we propose a solution to a novel generalized SSE problem in which full subsystems can be compromised, corrupting both the actuation and measurement signals. For a full system with p measurements, the proposed sliding mode observer (SMO)-based solution allows for up to p attack channels which can be arbitrarily distributed amongst attacks on actuation and measurement signals. This is a much larger class of attacks than considered in the existing literature. The method is demonstrated on 10 interconnected mass-spring-damper subsystems.
|
|
